Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
The competitive strengths of the company are:
1. Customer-centric and order driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing and sales network
5. Diversified business operations
Company Promoters:
Mr. Hemal V. Mehta and Mr. Sachin V. Mehta are the promoters of the company.
Company Financials:
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16
2/2019 Sudarshan Pharma IPO Date, Price, GMP, Review & Details
https://www.chittorgarh.com/ipo/sudarshan-pharma-ipo/992/ 2/10
Particulars For the year/perio(d/d eefnadueltd.a s(pin) Rs. Lakhs)
Total Assets 4,998.71 3,096.37 1,992.93 827.24
Total Revenue 14,001.96 8,976.43 5,551.72 3,794.33
Profit After Tax 234.79 73.98 15.63 9.27
Objects of the Issue:
The Net Proceeds from the Issue are proposed to be utilized by the Company for the following objects:
1) To set up a dedicated manufacturing facility for Pharmaceutical Business;
2) Distribution and Warehousing Centre's & Purchase of Corporate Office;
3) Additional Working Capital;
4) General Corporate Expenses; and
5) To meet the expenses of the Issue.
Sudarshan Pharma IPO Details
Issue Open
Issue Type Fixed Price Issue IPO
Issue Size 3,440,000 Eq Shares of Rs 10
(aggregating up to Rs 25.80 Cr)
Face Value Rs 10 Per Equity Share
Issue Price Rs 75 Per Equity Share
Market Lot 1600 Shares
Min Order Quantity 1600 Shares
Listing At NSE SME
Sudarshan Pharma IPO Promoter Holding
Pre Issue Share Holding 89.29%
Post Issue Share Holding 65.63%
Company Contact Information
Sudarshan Pharma Industries Limited
301, 3rd Floor, Aura Biplex,
Above Kalyan Jewellers, S V Road,
Borivali (West), Mumbai - 400 092,
Phone: +91 22 242221111
Email: compliance.spil@gmail.com
Website: http://www.sudarshanpharma.com
Sudarshan Pharma IPO Registrar
Karvy Computershare Private Limited
Karvy Registry House, 8-2-596, St. No. 1,
Banjara Hills, Hyderabad - 500 034
Andhra Pradesh, India
Phone: +91-40-23312454
Email: einward.ris@karvy.com
Website: https://karisma.karvy.com
Latest Share Market News, Latest Share News, Latest Share Market Tips, Latest Share Market Videos, Latest Share Market News In Hindi, Latest Share Recommendations , Latest Stock Market News, Latest Stock Market Recommendations , Latest Stock Market News India, Latest Stock News India, Latest Stock Picks, Latest Stock Market Analysis Market Watch, Latest Stock Market Videos
No comments:
Post a Comment